Given the IL-9 induction by purified pDCs demonstrated in a previous study [18], we hypothesized that OX40L overexpressed by pDCs from MS patients is involved in stimulating IL-9 by naïve CD4 T cells differentiated in Th cells. This evidence concerns the gene CD4 and myeloid sarcoma.